Concepedia

Author

F. Mirshahi

Inserm

Also Known As

F Mirshahi, F. MIRSHAHI, F. Mirshahi, Farrokh Mirshahi

14

Publications

716

Citations

9

H-Index

38

Concepts

All Affiliations

InsermHôtel-Dieu de ParisHôpital Saint-LouisHôpital LariboisièreCentre de Recherche des Cordeliers
FM

About

F. Mirshahi is an author at Inserm specializing in medicine, vascular biology, and atherosclerosis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

293

2

Cell Biology

3

3

259

3

Cellular Physiology

2

2

248

4

Health Sciences

1

1

11

5

Social Sciences

1

1

34

F. Mirshahi

×

9

Publications

701

Citations

9

H-Index

YearCitations

SDF-1 Activity on Microvascular Endothelial Cells

F. Mirshahi, Jérôme Pourtau, Hong Li,

Thrombosis Research

2000

235

Expression of Concern: Inhibition of endothelial cell migration by cerivastatin, an HMG‐CoA reductase inhibitor: contribution to its anti‐angiogenic effect

Loı̈c Vincent, Wenming Chen, Hong Li,

FEBS Letters

2001

205

Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models

Claudine Soria, F. Mirshahi, Paule Opolon,

Arteriosclerosis Thrombosis and Vascular Biology

2002

128

Immunochemical Detection of the Mineralocorticoid Receptor in Rat Brain

Monica Agarwal, F. Mirshahi, Massoud Mirshahi,

Neuroendocrinology

1993

34

Cyclooxygenase‐2 activity is necessary for the angiogenic properties of oncostatin M

Jérôme Pourtau, F. Mirshahi, Hong Li,

FEBS Letters

1999

31

Evidence for receptor-mediated mineralocorticoid action in rat osteoblastic cells

M.K. Agarwal, F. Mirshahi, Massoud Mirshahi,

American Journal of Physiology-Cell Physiology

1996

23

The role of fibroblasts in organization and degradation of a fibrin clot.

Manouchehr Mirshahi, Bruno Azzarone, Jeannette Soria,

PubMed

1991

21

Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitor

F. Mirshahi, Marc Vasse, Alain Tedgui,

Blood Coagulation & Fibrinolysis

2002

13

Fibrinogen: a vascular risk factor, why? Contributing effect of oncostatin M on both fibrinogen biosynthesis by hepatocytes and participation in atherothrombotic risk related to modifications of endothelial cells.

F. Mirshahi, Marc Vasse, Loı̈c Vincent,

PubMed

2001

11

Page 1